Conestoga Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-3,795
Closed -$250K – 124
2017
Q4
$250K Hold
3,795
– – 0.01% 114
2017
Q3
$227K Hold
3,795
– – 0.01% 113
2017
Q2
$246K Hold
3,795
– – 0.01% 107
2017
Q1
$237K Hold
3,795
– – 0.01% 105
2016
Q4
$219K Buy
3,795
+100
+3% +$5.91K 0.01% 112
2016
Q3
$220K Hold
3,695
– – 0.02% 109
2016
Q2
$229K Hold
3,695
– – 0.02% 104
2016
Q1
$228K Buy
+3,695
New +$218K 0.02% 104

Other funds holding XRAY

Conestoga Capital Advisors's XRAY Position: Q1 2018 in Review

Conestoga Capital Advisors sold out of Dentsply Sirona (XRAY) in Q1 2018, closing a stake of 3,795 shares — an estimated $250K sold.

Conestoga Capital Advisors first reported a position in XRAY in Q1 2016 and held it in 8 quarters. The position peaked at $250K in Q4 2017. 566 funds tracked by Wall St. Rank hold XRAY as of Q1 2018.

  • Conestoga Capital Advisors reported no remaining Dentsply Sirona position as of Q1 2018 after selling out during the quarter.
  • Conestoga Capital Advisors sold 3,795 Dentsply Sirona shares in Q1 2018, an estimated $250K.
  • Conestoga Capital Advisors first reported a position in Dentsply Sirona in Q1 2016 and held it in 8 quarters.
  • Conestoga Capital Advisors's Dentsply Sirona position peaked at $250K in Q4 2017.
  • 566 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2018.

Based on Conestoga Capital Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.